People · Operator
Named in public records as an officer, director or promoter · active 2011–2020 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| VitaPath Genetics, Inc. | — | Biotechnology | Series A | $13.9M | $182.1M | 2011 |
| ZappyLab Inc | — | Other Technology | Seed | $4.5M | $127.5M | 2014 |
Jasper Rine at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jasper Rine on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Borrus | 1 | 7 |
| Rowan Chapman | 1 | 7 |
| Bruce Cohen | 1 | 7 |
| Cyrus Harmon | 1 | 2 |
| Catherine M. Burzik | 1 | 2 |
| Tommy Doyle | 1 | 1 |
| Ilan Nissan | 1 | 1 |
| Leonid Teytelman | 1 | 1 |
| Alexei Stoliartchouk | 1 | 1 |
| Irina Makkaveeva | 1 | 1 |
| Richard Taylor | 1 | 1 |
| Girish Putcha | 1 | 1 |
| Dennis Gilbert | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.